68Ga-PSMA-PET/CT imaging offers precise tumor and metastasis localization, while 177Lu PSMA therapies have demonstrated significant efficacy in extending survival in metastatic PCa patients, as corroborated by numerous clinical studies (21, 22). This evidence concerns the gene FOLH1 and posterior cortical atrophy.